Tekton Research LLC
08/17/2026 | Press release | Archived content
Austin Site Screens First Participant Globally for Boehringer Ingelheim Systemic Sclerosis Study
Austin Site Screens First Participant Globally for Boehringer Ingelheim Systemic Sclerosis Study
August 17, 2026
Tekton's Austin, TX, team screened the first participant globally for Boehringer Ingelheim's Phase 3 study evaluating nerandomilast for systemic sclerosis.
Congratulations to Paul Pickrell, MD, and our entire Austin team on this milestone!
Posted in News
Tekton Research LLC published this content on August 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 23, 2026 at 10:50 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]